You are here
Cepravin® Dry Cow 250 mg Intramammary suspension for cattle (dairy cows at drying-off)
Cepravin Dry Cow is a long-acting intramammary suspension containing Cefalonium; a broad-spectrum first-generation cephalosporin antibiotic effective against predominantly Gram-positive bacteria, to be given at drying off.
Presentation
White to cream coloured suspension.
Active ingredients
Each 3 g syringe contains:
Active substance:
Cefalonium (as cefalonium dihydrate) 250 mg
Target species
Cattle (dairy cows at drying-off).
Indications for use
Recommended for routine dry cow therapy to treat existing sub-clinical mastitis and to prevent new infections which occur during the drying-off period.
Withdrawal periods
Meat and offal: 21 days after last treatment.
Milk: Milk for human consumption may only be taken 96 hours after calving.
If calving occurs before 54 days after treatment, milk for human consumption may be taken after 54 days plus 96 hours after treatment, ensuring that the milk from at least 7 complete milking is discarded.
The absence of antibiotic should be confirmed by testing before its milk is used for human consumption. This is advisable because of variation in the milking cow’s ability to excrete antibiotic from dry cow products. In cows suffering from hypocalcaemia, it may be necessary to discard milk for a longer period.
Packaging
Single dose 3 g white polyethylene syringes with a red polyethylene dual push-fit cap.
Cardboard box of 20 intramammary syringes and cleaning towels;
Plastic bucket of 144 intramammary syringes and cleaning towels;
‘Herd Pack’ of 200 intramammary syringes (10 boxes of 20 syringes and cleaning towels).
Not all pack sizes may be marketed.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: February 2026
